Figure 2
Kaplan-Meier curves of overall survival (OS) and disease-free survival (DFS) for different treatment strategies in SCCC. (A and B): Comparisons between survival rates in patients who received adjuvant chemotherapy (etoposide + cisplatin [EP]; or paclitaxel + cisplatin [TP]) as part of their adjuvant treatment, compared to those who received alternative adjuvant therapies. (C and D) Comparisons between the survival rates in patients who received adjuvant chemotherapy (CT), adjuvant radiotherapy (RT), adjuvant chemoradiotherapy (CT + RT), or no adjuvant therapy (NO).